Inoculum effect on the efficacies of amoxicillin-clavulanate, piperacillin-tazobactam, and imipenem against extended-spectrum β-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli in an experimental murine sepsis model.
about
Antimicrobial Activity and Resistance: Influencing Factors.A statistical approach for determination of disk diffusion-based cutoff values for systematic characterization of wild-type and non-wild-type bacterial populations in antimicrobial susceptibility testing.A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceaeβ-lactam/β-lactamase inhibitor combinations: from then to now.Updates in the Management of Cephalosporin-Resistant Gram-Negative Bacteria.Use of β-Lactam/β-Lactamase Inhibitors for Extended-Spectrum-β-Lactamase Infections: Defining the Right Patient Population.Unmet needs in the management of intra-abdominal infections.Piperacillin-tazobactam vs. imipenem-cilastatin as empirical therapy in hematopoietic stem cell transplantation recipients with febrile neutropenia.The Resistant-Population Cutoff (RCOFF): a New Concept for Improved Characterization of Antimicrobial Susceptibility Patterns of Non-Wild-Type Bacterial Populations.Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producing Escherichia coli.Point-Counterpoint: Piperacillin-tazobactam should be used to treat infections with ESBL-positive organisms.Can a pharmacokinetic/pharmacodynamic (PKPD) model be predictive across bacterial densities and strains? External evaluation of a PKPD model describing longitudinal in vitro data.Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.
P2860
Q33790192-82C43DED-A6C7-43F5-AB15-2C872692EAC2Q35607484-BCCAF0A9-E941-4675-BFCA-5C38E7AFD727Q37023191-692C8D98-B3F1-4B31-BC1C-CB502F1B1806Q38264182-FEACB8FF-9053-469A-BDDA-F7CD8FF76400Q38981397-06E57A47-3960-4351-80BA-0E63B5C70055Q39353134-67ABC0AE-80E5-4659-9D0B-2169C9ECB509Q40079705-764262C7-3718-420A-B441-F8937E55292CQ40125597-6F9F4826-1AB6-4B31-B6F4-6C254CFAF7BFQ40672387-A5E973FA-CA68-41A8-B922-2301861EB593Q40735145-BFC6FFC5-8ED1-4279-B372-563CFFC853E2Q47315442-E0A4112A-F46C-40D0-9439-E2D767638109Q47897914-1AFD3CD6-71E7-4DD8-8D02-73DDA91F44B6Q52695014-8553C74A-6988-410C-B5D9-106A6BF05A8E
P2860
Inoculum effect on the efficacies of amoxicillin-clavulanate, piperacillin-tazobactam, and imipenem against extended-spectrum β-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli in an experimental murine sepsis model.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Inoculum effect on the efficac ...... erimental murine sepsis model.
@en
type
label
Inoculum effect on the efficac ...... erimental murine sepsis model.
@en
prefLabel
Inoculum effect on the efficac ...... erimental murine sepsis model.
@en
P2093
P2860
P50
P356
P1476
Inoculum effect on the efficac ...... perimental murine sepsis model
@en
P2093
P2860
P304
P356
10.1128/AAC.02190-12
P407
P577
2013-02-25T00:00:00Z